These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3728035)

  • 21. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
    Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
    Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the in vitro interaction of D-penicillamine with antacids.
    Allgayer H; Paumgartner G
    Arzneimittelforschung; 1983; 33(3):417-8. PubMed ID: 6683517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interaction between papaverine hydrochloride and antacids].
    Mielcarek J; Sapór J
    Acta Pol Pharm; 1992; 49(5-6):23-6. PubMed ID: 16092195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leydig cell death in rats exposed to bismuth subnitrate.
    Pedersen LH; Stoltenberg M; Ernst E; West MJ
    J Appl Toxicol; 2003; 23(4):235-8. PubMed ID: 12884406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative in vitro evaluation of a new bismuth salt bismuth aluminate.
    BATESON PR
    J Pharm Pharmacol; 1958 Feb; 10(2):123-31. PubMed ID: 13502848
    [No Abstract]   [Full Text] [Related]  

  • 26. Adsorption of bile acids and lysolecithin by antacids.
    Begemann F; Schumpelick V; Bandomer G
    Scand J Gastroenterol Suppl; 1981; 67():191-3. PubMed ID: 6941407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of flow rate and type of i.v. container on adsorption of diazepam to i.v. administration systems.
    Yliruusi JK; Uotila JA; Kristoffersson ER
    Am J Hosp Pharm; 1986 Nov; 43(11):2795-9. PubMed ID: 3799617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro-adsorption of some drugs on antacids.
    Khalil SA; Moustafa MA
    Pharmazie; 1973 Feb; 28(2):116-8. PubMed ID: 4631571
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental study of the effects of the prolonged ingestion of bismuth subnitrate combined with other substances].
    Lechat P; Morel-Maroger L; Cluzan R; Flouvat F; Fontagné J
    Therapie; 1968; 23(2):445-57. PubMed ID: 5701520
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adsorption of tetracycline and oxytetracycline on Alusal].
    Mielcarek J; Sapór J; Pawlaczyk J
    Acta Pol Pharm; 1992; 49(3):23-8. PubMed ID: 16092407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro monitoring of ciprofloxacin antacids interactions by UV & HPLC.
    Sultana N; Arayne MS; Hussain F
    Pak J Pharm Sci; 2005 Oct; 18(4):23-31. PubMed ID: 16380354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of dihydroxyaluminum allantoinate and chlorhydroxyaluminum allantoinate. V. Effect on cicatrization of gastric ulcer].
    CAHEN R; PESSONNIER A
    Ann Pharm Fr; 1963 May; 21():405-11. PubMed ID: 14017702
    [No Abstract]   [Full Text] [Related]  

  • 34. [Value of a bismuth subnitrate + sorbitol combination (presented in tablets) in digestive pathology].
    Dissard P
    Lyon Med; 1970 Sep; 224(28):95-6. PubMed ID: 5455111
    [No Abstract]   [Full Text] [Related]  

  • 35. [Poisoning by aspirin and bismuth subnitrate in children].
    LOUBRY P
    Concours Med; 1955 Feb; 77(6):521-4. PubMed ID: 14352591
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets.
    Yliruusi JK; Uotila JA; Kristoffersson ER
    Am J Hosp Pharm; 1986 Nov; 43(11):2789-94. PubMed ID: 3799616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.
    de Boer WA
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):697-700. PubMed ID: 10445785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bismuth guiacol glycolate and bismuth thymol glycolate].
    RUGGIERI R
    G Med Mil; 1960; 110():634-6. PubMed ID: 13744616
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rheumatic anti-inflammatory agents and digestive intolerance. Preventive treatment with a weak bismuth subnitrate solution (Novismuth). Study of 172 cases].
    Benichou C; Du Lac de Fugères Y
    Gaz Med Fr; 1965 Sep; 72(17):2901-4. PubMed ID: 5849982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.